In a special workshop to be held in conjunction with this year’s annual meeting of the American Association for Clinical Chemistry (AACC), experts from the US Centers for Disease Control and Prevention (CDC) will discuss the upward trend in cases of both hepatitis C virus (HCV) and syphilis in the United States.
CDC presenters at the workshop will include Yetunde Fakile, PhD, team leader of CDC’s immunodiagnostics and proteomics reference and research laboratory; and Saleem Kamili, PhD, team leader of the assay development and diagnostic reference laboratory and deputy chief of the laboratory branch at CDC’s Division of Viral Hepatitis. The workshop will be chaired by Katherine Soreng, PhD, director of clinical scientific marketing at Siemens Healthcare Diagnostics, Tarrytown, NY.
Hepatitis C is especially challenging, as the majority of infections are thought to be undiagnosed. New testing guidelines from CDC are designed to improve detection of HCV infection and target patients for treatment. Syphilis infections continue to rise in many regions, increasing the risk of both disease progression and vertical transmission from pregnant women to their children. The workshop will review the advantages and limitations of both the traditional and reverse screening algorithms for syphilis.
Attendees can expect to attain insight into the current prevalence and screening recommendations for HCV, and an understanding of the nuances that distinguish traditional and reverse syphilis screening algorithms.
“CDC Recommendations on Syphilis and HCV Testing” will be held on Tuesday, July 28, from 10:15 am–11:15 am in Industry Theater 1 of Exhibit Hall B.
For more information, visit Siemens.
